Avid Bioservices Announces Grand Opening of New Early-Phase Center of Excellence Facility. Read the Release

Events

DCAT Week

Name: DCAT Week
Start: 2025-03-17T00:00:00-05:00
End: 2025-03-20T23:59:59-05:00
Location: Omni Berkshire Place

March 17, 2025 - March 20, 2025

DCAT Week is the premier global event held annually in New York City for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain. It is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

Details

Start: March 17, 2025
End: March 20, 2025
Event Category: Conference
Website: https://dcatweek.org/

Venue

Omni Berkshire Place
New York, NY United States

News

Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California
February 24, 2026
Press Release: Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California Costa Mesa, Calif. – [February 24, 2026] – Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand […]
Read more
Avid Bioservices Appoints Rich McAvoy as Chief Business Officer
January 15, 2026
Seasoned business and finance leader brings growth mindset to support Avid’s next phase expansion and client execution TUSTIN, Calif. — [January 15, 2026] — Avid Bioservices, a leading contract development […]
Read more
Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer
October 7, 2025
The newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth. TUSTIN, Calif., November 10, 2025 – Avid […]
Read more
Avid Bioservices Welcomes Kenneth Bilenberg as New CEO
September 15, 2025
Tustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]
Read more
CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
August 5, 2025
SOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]
Read more

< View Older News

Events

DCAT Week

Details

Venue

News

Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California

Avid Bioservices Appoints Rich McAvoy as Chief Business Officer

Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer

Avid Bioservices Welcomes Kenneth Bilenberg as New CEO

CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content: